PDL BioPharma, Inc. EBIT Margin

EBIT Margin of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT Margin growth rates and interactive chart. Earnings before interest and taxes margin is an indicator of a company's profitability. Calculated as earnings before interest and taxes (EBIT) divided by revenue. It is useful for comparison of companies with different debt levels and tax rates. And EBIT margin gives a clear picture about the underlying profitability of a company's core operations. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes.


Highlights and Quick Summary

  • EBIT Margin for the quarter ending June 29, 2020 was -264.11% (a -50.33% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT Margin decreased by -1335.31%
  • Annual EBIT Margin for 2019 was -182.29% (a 613.74% increase from previous year)
  • Annual EBIT Margin for 2018 was -25.54% (a -142.19% decrease from previous year)
  • Annual EBIT Margin for 2017 was 60.54% (a 14.29% increase from previous year)
  • Twelve month EBIT Margin ending June 29, 2020 was -247.02% (a 8.15% increase compared to previous quarter)
  • Twelve month trailing EBIT Margin decreased by -1103.33% year-over-year
Trailing EBIT Margin for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-247.02% -228.41% -182.29% 24.62%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT Margin of PDL BioPharma, Inc.

Most recent EBIT Marginof PDLI including historical data for past 10 years.

Interactive Chart of EBIT Margin of PDL BioPharma, Inc.

PDL BioPharma, Inc. EBIT Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -264.11% -531.71%
2019 2576.67% 21.38% -124.12% -122.74% -182.29%
2018 74.25% 54.11% -268.65% 11.14% -25.54%
2017 43.91% 51.99% 78.41% 40.72% 60.54%
2016 -11.53% 60.88% 52.91% 90.45% 52.97%
2015 90.72% 93.22% 94.62% 94.88% 93.21%
2014 84.86% 96.55% 95.75% 96.65% 93.99%
2013 93.21% 92.09% 95.43% 92.18% 93.48%
2012 91.63% 93.37% 95.91% 91.02% 93.31%
2011 93.38% 95.27% 96.91% 93.07% 94.93%
2010 -37.34% 87.15% 92.67% 61.19%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.